Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) EBT Margin (2017 - 2020)

Historic EBT Margin for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to 18325.64%.

  • Cogent Biosciences' EBT Margin fell 171486800.0% to 18325.64% in Q3 2020 from the same period last year, while for Dec 2020 it was 1042.5%, marking a year-over-year decrease of 9006600.0%. This contributed to the annual value of 1042.5% for FY2020, which is 9006600.0% down from last year.
  • Per Cogent Biosciences' latest filing, its EBT Margin stood at 18325.64% for Q3 2020, which was down 171486800.0% from 1401.52% recorded in Q2 2020.
  • In the past 5 years, Cogent Biosciences' EBT Margin ranged from a high of 15.05% in Q4 2019 and a low of 18325.64% during Q3 2020
  • Its 4-year average for EBT Margin is 1634.34%, with a median of 327.26% in 2017.
  • Over the last 5 years, Cogent Biosciences' EBT Margin had its largest YoY gain of 2962600bps in 2020, and its largest YoY loss of -171486800bps in 2020.
  • Cogent Biosciences' EBT Margin (Quarter) stood at 319.41% in 2017, then rose by 29bps to 225.91% in 2018, then soared by 107bps to 15.05% in 2019, then plummeted by -121857bps to 18325.64% in 2020.
  • Its last three reported values are 18325.64% in Q3 2020, 1401.52% for Q2 2020, and 86.67% during Q1 2020.